All News

Integra LifeSciences Reports Second Quarter 2024 Financial Results

Learn to Enjoy the Climb

Integra LifeSciences Provides Updated Plans For Its Manufacturing Facility In Braintree, Massachusetts

Growing as a Leader and Advocate for Others

Integra LifeSciences Reports First Quarter 2024 Financial Results

Advancing Leaders Through Innovation

46 Years of Creating Magnificent Instruments

Daniel Ray, team manager at our Saint-Aubin, France manufacturing site has built a lifetime of memories working with his hands.

Integra LifeSciences Completes The Acquisition Of Acclarent, Inc.

Integra today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions. The addition of Acclarent's innovative product portfolio expands the breadth of Integra’s market-leading brands and provides immediate scale and accretive growth via a dedicated sales channel.

Healthcare Businesswomen’s Association Recognizes Topaz Kirlew During Women’s History Month

Congratulations to Topaz Kirlew, vice president, Regulatory Affairs, a 2024 Healthcare Businesswomen’s Association (HBA) Luminary! Topaz received this honor for Accelerating Transformational Leadership and driving significant positive change.

Soaring to New Heights

Integra LifeSciences Launches MicroMatrix® Flex To Provide Convenient Access To Hard-To-Reach Areas In Complex Cases

Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matrix (UBM) technology

Integra LifeSciences Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides 2024 Financial Guidance

Integra LifeSciences reported financial results for the fourth quarter and full year 2023.